Announcement on Wholly-owned Subsidiary Changing Business License
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Wholly-owned Subsidiary Changing Business License
Filed with SSE · · 2 pages · Chinese
Release
Beijing Foyou Pharma Co., Ltd. on 6ix
Earlier from Beijing Foyou Pharma
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Obtaining Drug Registration Certificate for Lansoprazole Enteric Capsules
- Announcement on Approval Notice of the Supplementary Application for Drugs Obtained by the Subsidiary
- Announcement on Obtaining Drug Registration Certificate for Bifonazole Solution
- Announcement on Obtaining Drug Registration Certificate for Amorolfine Hydrochloride Liniment
Later from Beijing Foyou Pharma
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Resolutions of the 2nd Meeting of the 3rd Board of Supervisors
- Announcement on Obtaining Drug Registration Certificate for Levothyroxine Sodium Tablets
- Announcement on Obtaining Drug Registration Certificate for Amlodipine Besilate and Benazepril Hydrochloride Capsules
- Announcement on Obtaining Drug Registration Certificate for Arotinolol Hydrochloride Tablets
Follow Beijing Foyou Pharma into a list and get an email when it puts out news.
Follow Beijing Foyou Pharma